Active Clinical Trials

Diabetic Retinopathy and Diabetic Macular Edema Protocol W:


Intravitreous Anti-VEGF Treatment for Prevention of Vision                                Threatening Diabetic Retinopathy in Eyes at High Risk

       Status: Enrolled Protocol AC:


Randomized Trial of Intravitreous Aflibercept versus Intravitreous  Bevacizumab + Deferred Afliberceptf or Treatment of Central-Involved Diabetic Macular Edema

       Status: Actively enrolling


Age-Related Macular Degeneration

   Dry Macular Degeneration:

Phase III , Multi-Center, Randomized, Double-Masked, Sham –Controlled study to compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections In Patients with Geographic Atrophy secondary to Age-Related Macular Degeneration. 

Status: Anticipated start in October, 2018

  Wet Macular Degeneration:


GBV-102, long-acting depot therapy for neovascular age-related macular  degeneration.

Status: Anticipated start in early 2019